ACCESSION: MSBNK-SMB_Measured-HSA001P0115002
RECORD_TITLE: Characterized; N,N-Dimethylformamide; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 59
COMMENT: RAW_SPEC {'17_posi_1580': {'bp': 206037.0, 'sum': 934877.0}, '17_posi_1517': {'bp': 174528.0, 'sum': 920379.0}, '17_posi_1454': {'bp': 164769.0, 'sum': 833504.0}, '19_posi_1685': {'bp': 161848.0, 'sum': 819292.0}, '19_posi_1560': {'bp': 161588.0, 'sum': 753696.0}, '18_posi_1661': {'bp': 159748.0, 'sum': 727474.0}, '16_posi_1519': {'bp': 159741.0, 'sum': 883101.0}, '9_posi_1518': {'bp': 159506.0, 'sum': 822170.0}, '12_posi_1556': {'bp': 159101.0, 'sum': 809256.0}, '6_posi_1601': {'bp': 158698.0, 'sum': 794587.0}, '3_posi_1531': {'bp': 157938.0, 'sum': 878141.0}, '19_posi_1622': {'bp': 157369.0, 'sum': 803544.0}, '16_posi_1581': {'bp': 156471.0, 'sum': 848826.0}, '12_posi_1619': {'bp': 155533.0, 'sum': 793043.0}, '8_posi_1538': {'bp': 154006.0, 'sum': 822838.0}, '9_posi_1581': {'bp': 153608.0, 'sum': 854740.0}, '17_posi_1643': {'bp': 153474.0, 'sum': 813937.0}, '10_posi_1571': {'bp': 152583.0, 'sum': 826158.0}, '18_posi_1598': {'bp': 151519.0, 'sum': 762869.0}, '11_posi_1601': {'bp': 151420.0, 'sum': 759090.0}, '13_posi_1580': {'bp': 150883.0, 'sum': 752139.0}, '15_posi_1581': {'bp': 150587.0, 'sum': 788298.0}, '5_posi_1573': {'bp': 150402.0, 'sum': 818973.0}, '4_posi_1456': {'bp': 150121.0, 'sum': 749172.0}, '4_posi_1594': {'bp': 149822.0, 'sum': 764208.0}, '16_posi_1645': {'bp': 148949.0, 'sum': 752765.0}, '4_posi_1519': {'bp': 148541.0, 'sum': 797121.0}, '14_posi_1558': {'bp': 148092.0, 'sum': 835662.0}, '12_posi_1495': {'bp': 147588.0, 'sum': 839698.0}, '1_posi_1510': {'bp': 147346.0, 'sum': 832905.0}, '14_posi_1495': {'bp': 146928.0, 'sum': 771259.0}, '6_posi_1528': {'bp': 144660.0, 'sum': 824651.0}, '9_posi_1448': {'bp': 143429.0, 'sum': 752446.0}, '16_posi_1456': {'bp': 143156.0, 'sum': 741297.0}, '10_posi_1643': {'bp': 143066.0, 'sum': 715776.0}, '8_posi_1413': {'bp': 142585.0, 'sum': 715289.0}, '8_posi_1477': {'bp': 141802.0, 'sum': 781817.0}, '17_posi_1707': {'bp': 141114.0, 'sum': 764656.0}, '14_posi_1620': {'bp': 141043.0, 'sum': 805153.0}, '15_posi_1519': {'bp': 138933.0, 'sum': 688880.0}, '18_posi_1725': {'bp': 138866.0, 'sum': 676319.0}, '15_posi_1644': {'bp': 138666.0, 'sum': 695367.0}, '9_posi_1645': {'bp': 138477.0, 'sum': 725154.0}, '11_posi_1539': {'bp': 138319.0, 'sum': 738355.0}, '10_posi_1496': {'bp': 138317.0, 'sum': 764859.0}, '8_posi_1602': {'bp': 138269.0, 'sum': 810963.0}, '19_posi_1812': {'bp': 137888.0, 'sum': 671174.0}, '5_posi_1495': {'bp': 135730.0, 'sum': 787635.0}, '2_posi_1550': {'bp': 135058.0, 'sum': 770368.0}, '12_posi_1684': {'bp': 134691.0, 'sum': 684038.0}, '11_posi_1476': {'bp': 134097.0, 'sum': 718764.0}, '11_posi_1665': {'bp': 133376.0, 'sum': 681124.0}, '1_posi_1609': {'bp': 132291.0, 'sum': 698332.0}, '3_posi_1622': {'bp': 131746.0, 'sum': 729127.0}, '2_posi_1466': {'bp': 131277.0, 'sum': 735647.0}, '19_posi_1748': {'bp': 130959.0, 'sum': 715264.0}, '3_posi_1456': {'bp': 130953.0, 'sum': 766637.0}, '4_posi_1666': {'bp': 129579.0, 'sum': 659993.0}, '14_posi_1685': {'bp': 119835.0, 'sum': 611869.0}}
COMMENT: RETENTION_TIME_STDEV 0.168
COMMENT: PRECURSOR_M/Z_RAW 115.086571
COMMENT: PRECURSOR_M/Z_STDEV 0.000033
COMMENT: PRECURSOR_IN_MS1 mz 115.086564; int 95.963; delta(ppm) 1.416159
COMMENT: PROPOSED_CHARGE_STATE +1; mz 116.089896; int 4.765; cor 0.679
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 156.113179; int 217.917; cor 0.690
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 156.113179; int 217.917; cor 0.690
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 156.113179; int 217.917; cor 0.690
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.210; C5H10N2O; [M+H]+; delta(ppm) -0.210380
COMMENT: PROPOSED_MF SevenGoldenRules 0.301; C3H7NO; [M+ACN+H]+; delta(ppm) -0.301152
COMMENT: PROPOSED_MF MS-FINDER 3.390; C3H7NO; [M+ACN+H]+; delta(ppm) 150139.747441
COMMENT: PROPOSED_MF MS-FINDER 3.277; C5H10N2O; [M+H]+; delta(ppm) -0.211907
COMMENT: PROPOSED_MF SIRIUS5_Sirius 27.133; C3H7NO; [M+C2H3N+H]+; delta(ppm) -0.211907
COMMENT: PROPOSED_MF SIRIUS5_Sirius 27.133; C5H10N2O; [M+H]+; delta(ppm) -0.211907
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C3H7NO; [M+C2H3N+H]+; delta(ppm) -0.211907
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H10N2O; [M+H]+; delta(ppm) -0.211907
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.107; C5H10N2O; [M+H]+; delta(ppm) -0.211907
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.107; C3H7NO; [M+C2H3N+H]+; delta(ppm) -0.211907
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.045; C3H8N5; [M+H]+; delta(ppm) 11.454778
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.045; CH5N4; [M+C2H3N+H]+; delta(ppm) 11.454778
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H10N2O; [M+H]+; delta(ppm) -0.211907
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C3H7NO; [M+C2H3N+H]+; delta(ppm) -0.211907
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.811; GYOBZYGGVLLHBK-UHFFFAOYSA-N; [M+H]+; O=NC1CCNCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.724; RLFFWWKJSJOYMQ-UHFFFAOYSA-N; [M+H]+; O=C1NCCCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.705; YCCMTCQQDULIFE-UHFFFAOYNA-N; [M+H]+; NC1CCCNC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.658; LCDCPQHFCOBUEF-UHFFFAOYSA-N; [M+H]+; NC(=O)N1CCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.500; VLJNHYLEOZPXFW-SGAVLPGINA-N; [M+H]+; NC(=O)[C@@H]1CCCN1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.674; ZMXDDKWLCZADIW-UHFFFAOYSA-N; [M+ACN+H]+; N,N-Dimethylformamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.592; YCCMTCQQDULIFE-UHFFFAOYNA-N; [M+H]+; 3-Amino-2-piperidone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.502; BCDGQXUMWHRQCB-UHFFFAOYSA-N; [M+ACN+H]+; Aminoacetone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.405; UWSDONTXWQOZFN-UHFFFAOYSA-N; [M+H]+; N-nitrosopiperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.398; PCXDJQZLDDHMGX-UHFFFAOYSA-N; [M+ACN+H]+; 3-Aminopropionaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.375; RLFFWWKJSJOYMQ-UHFFFAOYSA-N; [M+H]+; CNP0443523
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.348; PXAJQJMDEXJWFB-UHFFFAOYSA-N; [M+ACN+H]+; acetone oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.301; GYOBZYGGVLLHBK-UHFFFAOYSA-N; [M+H]+; N-Mononitrosopiperazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.243; WZKJLPRUDLAWPS-UHFFFAOYSA-N; [M+H]+; 4-(2-aminoethyl)azetidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.211; LCDCPQHFCOBUEF-UHFFFAOYSA-N; [M+H]+; UNPD187178
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.186; VLJNHYLEOZPXFW-SGAVLPGINA-N; [M+H]+; L-prolinamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.153; OHLUUHNLEMFGTQ-UHFFFAOYSA-N; [M+ACN+H]+; N-methylacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.109; SJFKGZZCMREBQH-UHFFFAOYSA-N; [M+ACN+H]+; methyl ethanimidate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.101; KZMQZFPRPILIHO-UHFFFAOYSA-N; [M+ACN+H]+; 2-(methylamino)acetaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.101; WYNCHZVNFNFDNH-UHFFFAOYSA-N; [M+ACN+H]+; 1,3-oxazolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.092; CYSGHNMQYZDMIA-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.034; QLNJFJADRCOGBJ-UHFFFAOYSA-N; [M+ACN+H]+; propionamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.970; KFUSIRMDWATCKL-UHFFFAOYSA-N; [M+ACN+H]+; 1-aminocyclopropan-1-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.863; CIISBYKBBMFLEZ-UHFFFAOYSA-N; [M+ACN+H]+; 1,2-oxazolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.442; IFDZZSXEPSSHNC-ONEGZZNKSA-N; [M+ACN+H]+; UNPD57536
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VLJNHYLEOZPXFW-SGAVLPGINA-N; [M+H]+; L-prolinamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PCXDJQZLDDHMGX-UHFFFAOYSA-N; [M+ACN+H]+; 3-Aminopropionaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.932; CIISBYKBBMFLEZ-UHFFFAOYSA-N; [M+ACN+H]+; 1,2-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.931; KZMQZFPRPILIHO-UHFFFAOYSA-N; [M+ACN+H]+; 2-(methylamino)acetaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.920; WZKJLPRUDLAWPS-UHFFFAOYSA-N; [M+H]+; 4-(2-aminoethyl)azetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.917; LCDCPQHFCOBUEF-UHFFFAOYSA-N; [M+H]+; UNPD187178
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.904; RLFFWWKJSJOYMQ-UHFFFAOYSA-N; [M+H]+; CNP0443523
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.891; WYNCHZVNFNFDNH-UHFFFAOYSA-N; [M+ACN+H]+; 1,3-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.885; YCCMTCQQDULIFE-UHFFFAOYNA-N; [M+H]+; 3-Amino-2-piperidone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.784; GYOBZYGGVLLHBK-UHFFFAOYSA-N; [M+H]+; N-Mononitrosopiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.782; OHLUUHNLEMFGTQ-UHFFFAOYSA-N; [M+ACN+H]+; N-methylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.725; CYSGHNMQYZDMIA-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.716; SJFKGZZCMREBQH-UHFFFAOYSA-N; [M+ACN+H]+; methyl ethanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.700; IFDZZSXEPSSHNC-ONEGZZNKSA-N; [M+ACN+H]+; UNPD57536
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.659; QLNJFJADRCOGBJ-UHFFFAOYSA-N; [M+ACN+H]+; propionamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.586; BCDGQXUMWHRQCB-UHFFFAOYSA-N; [M+ACN+H]+; Aminoacetone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.578; KFUSIRMDWATCKL-UHFFFAOYSA-N; [M+ACN+H]+; 1-aminocyclopropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.556; PXAJQJMDEXJWFB-UHFFFAOYSA-N; [M+ACN+H]+; acetone oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.383; UWSDONTXWQOZFN-UHFFFAOYSA-N; [M+H]+; N-nitrosopiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.341; ZMXDDKWLCZADIW-UHFFFAOYSA-N; [M+ACN+H]+; N,N-Dimethylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.330; ZMXDDKWLCZADIW-UHFFFAOYSA-N; [M+ACN+H]+; N,N-dimethylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.392; UWSDONTXWQOZFN-UHFFFAOYSA-N; [M+H]+; 1-nitrosopiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.375; CYSGHNMQYZDMIA-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.101; OHLUUHNLEMFGTQ-UHFFFAOYSA-N; [M+ACN+H]+; N-methylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.058; VLJNHYLEOZPXFW-BYPYZUCNSA-N; [M+H]+; (2S)-pyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.973; WYNCHZVNFNFDNH-UHFFFAOYSA-N; [M+ACN+H]+; 1,3-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.944; QLNJFJADRCOGBJ-UHFFFAOYSA-N; [M+ACN+H]+; propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.411; KERBAAIBDHEFDD-UHFFFAOYSA-N; [M+ACN+H]+; N-ethylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.302; PCXDJQZLDDHMGX-UHFFFAOYSA-N; [M+ACN+H]+; 3-aminopropanal
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.269; YCCMTCQQDULIFE-UHFFFAOYSA-N; [M+H]+; 3-aminopiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.264; CIISBYKBBMFLEZ-UHFFFAOYSA-N; [M+ACN+H]+; 1,2-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.247; RLFFWWKJSJOYMQ-UHFFFAOYSA-N; [M+H]+; 1,3-diazepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.237; LCDCPQHFCOBUEF-UHFFFAOYSA-N; [M+H]+; pyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.206; MSSDTZLYNMFTKN-UHFFFAOYSA-N; [M+H]+; piperazine-1-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.178; IQHXABCGSFAKPN-UHFFFAOYSA-N; [M+H]+; pyrrolidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.160; IIRWPRRQZRCXBZ-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.157; HXJGFDIZSMWOGY-UHFFFAOYSA-N; [M+H]+; N-(2-aminoethyl)prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.155; GMWFCJXSQQHBPI-UHFFFAOYSA-N; [M+ACN+H]+; azetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; JELHGGHSSHUANV-UHFFFAOYSA-N; [M+H]+; 2-(azetidin-3-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; QHPGPVUYRVXSSO-UHFFFAOYSA-N; [M+H]+; 3-methylazetidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.112; BCDGQXUMWHRQCB-UHFFFAOYSA-N; [M+ACN+H]+; 1-aminopropan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; FABRNCRSZARATD-UHFFFAOYSA-N; [M+H]+; 3-aminocyclobutane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.107; PXAJQJMDEXJWFB-UHFFFAOYSA-N; [M+ACN+H]+; N-propan-2-ylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.107; NRQJSJSJLHBAGP-UHFFFAOYSA-N; [M+H]+; 3-(methylamino)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; DRRVROVYLJHJIV-UHFFFAOYSA-N; [M+H]+; 1,4-diazepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; QPPLBCQXWDBQFS-UHFFFAOYSA-N; [M+H]+; 1,4-diazepan-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.095; DMJZQILWVRAKET-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.095; COYPZADTXISTSJ-UHFFFAOYSA-N; [M+H]+; 1-methyl-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.094; BPRCXDKVLIAUTK-PWNYCUMCSA-N; [M+ACN+H]+; (1R,2R)-2-aminocyclopropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; JDQBJMHNGNZBIO-UHFFFAOYSA-N; [M+H]+; 2-amino-N-prop-2-enylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; BPUUSPXOKMMRFB-UHFFFAOYSA-N; [M+H]+; 2-(3,4-dihydropyrazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.080; XVDWZTJGQBNPFX-UHFFFAOYSA-N; [M+H]+; cyclobutylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; SILFUQGFSMYYME-UHFFFAOYSA-N; [M+H]+; 1-aminocyclobutane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; QLJGYAZBRDOGBU-UHFFFAOYSA-N; [M+H]+; 2-(1-aminocyclopropyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; KVIZTDNKHOCNAM-UHFFFAOYSA-N; [M+H]+; 4-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.077; UTNDHLQHBDFDLA-UHFFFAOYSA-N; [M+H]+; 1,4-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; BSPUWRUTIOUGMZ-SCSAIBSYSA-N; [M+H]+; (3R)-3-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; ASFOHWKEKBODLZ-UHFFFAOYSA-N; [M+H]+; 6-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; GOHZKUSWWGUUNR-UHFFFAOYSA-N; [M+H]+; 2-(4,5-dihydroimidazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; SODLPCCEKPQWAY-UHFFFAOYSA-N; [M+H]+; 5-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; PCVOBSZOJJBJJP-UHFFFAOYSA-N; [M+H]+; 2-(cyclopropylamino)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.053; SLZBOFGNZPNOOK-UHFFFAOYSA-N; [M+H]+; 4-aminopiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; NSPYRFXQDUFQOM-UHFFFAOYSA-N; [M+H]+; 1-ethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; GFOAHABINHRDKL-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.049; UIYPGDYKWVLEDA-UHFFFAOYSA-N; [M+H]+; 1,5-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.042; TXFBWVRKVAEOPA-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.034; ADCBCVDWUYMSGD-UHFFFAOYSA-N; [M+H]+; 3-amino-3-methylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.033; WGEHEKHOMIDZQR-UHFFFAOYSA-N; [M+H]+; (3-methyl-4,5-dihydro-1,2-oxazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; FKNQPMKUSCPENH-NSCUHMNNSA-N; [M+H]+; (E)-4-amino-N-methylbut-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; SJFKGZZCMREBQH-UHFFFAOYSA-N; [M+ACN+H]+; methyl ethanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; QVSUDDUBYYZVKX-UHFFFAOYSA-N; [M+H]+; N-methylazetidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.019; IOMUZVRDGGAWTI-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-4-methylazetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.018; VIDLMMHRVJNUGG-BYPYZUCNSA-N; [M+H]+; [(2S)-5-amino-3,4-dihydro-2H-pyrrol-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; FGXXCOXDQDQWHX-UHFFFAOYSA-N; [M+H]+; N-methylazetidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; APDCFRUAEFSNPV-BYPYZUCNSA-N; [M+H]+; (5S)-5-aminopiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.992; XOKBRZCNKAYJQA-UHFFFAOYSA-N; [M+H]+; N'-hydroxy-1-methylcyclopropane-1-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.989; OGPKKHIMHVLSJE-UHFFFAOYSA-N; [M+H]+; (5-methyl-4,5-dihydro-1,2-oxazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.982; CAYSWNDCZRTXGL-UHFFFAOYSA-N; [M+H]+; 2-amino-N-cyclopropylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; AXTLSNLDQDWQSJ-UHFFFAOYSA-N; [M+H]+; N,2-dimethylaziridine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.978; VLBALHTULJRKCS-UHFFFAOYSA-N; [M+H]+; 1-amino-N-methylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.975; IRLLLHYGMMQKFU-UHFFFAOYSA-N; [M+H]+; 4,4-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; SXGRRNXWWIQUOO-UHFFFAOYSA-N; [M+H]+; N-(azetidin-3-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; FYEGWALDOWGEQR-UHFFFAOYSA-N; [M+H]+; 5,5-dimethyl-4H-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.959; LWABIKVVWYCMII-UHFFFAOYSA-N; [M+H]+; 5,5-dimethyl-4H-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; JTEWXLMHFCOPAX-UHFFFAOYSA-N; [M+H]+; 4-ethyl-4,5-dihydro-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; GYOBZYGGVLLHBK-UHFFFAOYSA-N; [M+H]+; 4-nitrosopiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.951; DEAGOJXAHZYVRR-UHFFFAOYSA-N; [M+H]+; N'-hydroxycyclobutanecarboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; OHCXSLPXSUWTKQ-UHFFFAOYSA-N; [M+H]+; 4,4-dimethyl-5H-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.928; WBYJZPAHGAGMQX-SCSAIBSYSA-N; [M+H]+; (4R)-4-amino-1-methylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.928; VZDMTWJWRRUJED-SCSAIBSYSA-N; [M+H]+; (3R)-3-amino-1-methylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; KJCIMSSFGUGTGA-UHFFFAOYSA-N; [M+H]+; 1-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.902; QPMCUNAXNMSGTK-VKHMYHEASA-N; [M+ACN+H]+; (2S)-2-aminopropanal
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.898; VPZBJFGUILDYED-UHFFFAOYSA-N; [M+H]+; 3,5-dimethylimidazolidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; MDCDHGVIPGMQNR-UHFFFAOYSA-N; [M+H]+; 1-aminopiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; ZXLXXAGZVULNPB-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(azetidin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; OJEOJUQOECNDND-UHFFFAOYSA-N; [M+ACN+H]+; oxetan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.880; YJBPEAHLEMYMEC-UHFFFAOYSA-N; [M+H]+; 2-methylcyclopropane-1-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; YUJHTWYBKVAQEN-UHFFFAOYSA-N; [M+H]+; 1-(3-aminoazetidin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.872; OUAFMLDGDMRISR-UHFFFAOYSA-N; [M+H]+; oxolane-2-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.864; VHYMNMJOIQJRTJ-UHFFFAOYSA-N; [M+H]+; oxolane-3-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.829; ZCDCBMIBQMEIQA-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methoxy-2-methylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.819; HEZYPWDHDAPLSB-UHFFFAOYSA-N; [M+ACN+H]+; ethyl methanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.793; CRHLBNPXQYHPPW-UHFFFAOYSA-N; [M+H]+; 2-(2-methoxyethylamino)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; LMWHOJSLACFBSG-UHFFFAOYSA-N; [M+ACN+H]+; N-prop-2-enylhydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.778; IFDZZSXEPSSHNC-ONEGZZNKSA-N; [M+ACN+H]+; (NE)-N-propylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.728; DJJQQKQBBXUDCM-UHFFFAOYSA-N; [M+H]+; 3-(3-methyldiazirin-3-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.714; RJDIBXFCPXYMQK-UHFFFAOYSA-N; [M+H]+; 1-methylcyclopropane-1-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.690; KYUUPPKLZSVGMG-UHFFFAOYSA-N; [M+H]+; cyclobutanecarbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.690; GVPVKNZZLIICEQ-UHFFFAOYSA-N; [M+H]+; 2-cyclopropylacetohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.679; ZCOGQSHZVSZAHH-UHFFFAOYSA-N; [M+H]+; N,N-dimethylaziridine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; WBWJRDHRSVAKQQ-UHFFFAOYSA-N; [M+H]+; N-methylcyclopropanecarbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.534; KPTCZURLWZSRKB-UHFFFAOYSA-N; [M+ACN+H]+; O-prop-2-enylhydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.467; NDEOFSCLJFPNSR-UHFFFAOYSA-N; [M+ACN+H]+; 2-nitrosopropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.442; XWQOMZOQTMWNND-UHFFFAOYSA-N; [M+ACN+H]+; O-cyclopropylhydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -39.317; ZMXDDKWLCZADIW; [M+C2H3N+H]+; bmse000709
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -67.317; DRRVROVYLJHJIV; [M+H]+; zlchem 612
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -74.013; QPPLBCQXWDBQFS; [M+H]+; Ambpe3000755
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -74.988; KJCIMSSFGUGTGA; [M+H]+; 1-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -75.229; VLJNHYLEOZPXFW; [M+H]+; Prolinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -83.224; KZMQZFPRPILIHO; [M+C2H3N+H]+; Acetaldehyde, (methylamino)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -95.002; OHLUUHNLEMFGTQ; [M+C2H3N+H]+; Methylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -96.857; MSSDTZLYNMFTKN; [M+H]+; Formylpiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -97.270; KERBAAIBDHEFDD; [M+C2H3N+H]+; Ethylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -97.931; KVIZTDNKHOCNAM; [M+H]+; 4-Methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -98.376; QPMCUNAXNMSGTK; [M+C2H3N+H]+; Alaninal
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -102.481; QLNJFJADRCOGBJ; [M+C2H3N+H]+; Propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.699; IFDZZSXEPSSHNC; [M+C2H3N+H]+; ACMC-20ajtf
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.938; PXAJQJMDEXJWFB; [M+C2H3N+H]+; Acetoxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -108.450; BCDGQXUMWHRQCB; [M+C2H3N+H]+; aminoacetone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -112.624; PCXDJQZLDDHMGX; [M+C2H3N+H]+; 3-Aminopropanal
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.943; BSPUWRUTIOUGMZ; [M+H]+; Ambcb4028234
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -119.250; DJCMHDGLUZBVHN; [M+H]+; 1-imidazolidin-1-ylethanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -127.880; UWSDONTXWQOZFN; [M+H]+; Nitrosopiperidin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -131.298; GYOBZYGGVLLHBK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.043; UQQDYBCWIRAQKL; [M+C2H3N+H]+; methyl N-methylmethanimidate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.999; GFOAHABINHRDKL; [M+H]+; 5-Aminomethyl-pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.688; SJFKGZZCMREBQH; [M+C2H3N+H]+; Methyl acetimidate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.255; NXBRZAXPUJMKNJ; [M+H]+; 5-iminopentanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.851; RLFFWWKJSJOYMQ; [M+H]+; 2H-1, hexahydro-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.099; YCCMTCQQDULIFE; [M+H]+; Ornithine N5-lactam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.848; ADCBCVDWUYMSGD; [M+H]+; 2-Pyrrolidinone, 3-amino-3-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.171; RJDIBXFCPXYMQK; [M+H]+; 1-methylcyclopropanecarbohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.874; CRHLBNPXQYHPPW; [M+H]+; 2-(2-methoxyethylamino)acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.448; KPTCZURLWZSRKB; [M+C2H3N+H]+; o-Allylhydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -171.552; CYSGHNMQYZDMIA; [M+H]+; Rhonite 1
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.725; LCDCPQHFCOBUEF; [M+H]+; 1-Pyrrolidinecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.833; ZCOGQSHZVSZAHH; [M+H]+; N'',N-ethyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.349; CIISBYKBBMFLEZ; [M+C2H3N+H]+; Isoxazolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.534; HXJGFDIZSMWOGY; [M+H]+; N-(2-Aminoethyl)acrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.133; YUJHTWYBKVAQEN; [M+H]+; 1-(3-Aminoazetidin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.724; KFUSIRMDWATCKL; [M+C2H3N+H]+; 1-Aminocyclopropanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.375; UTNDHLQHBDFDLA; [M+H]+; 1,4-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.255; WYNCHZVNFNFDNH; [M+C2H3N+H]+; Oxazolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.953; OJEOJUQOECNDND; [M+C2H3N+H]+; 3-Oxetanamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.754; KYUUPPKLZSVGMG; [M+H]+; Oprea1_092053
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.228; AXTLSNLDQDWQSJ; [M+H]+; N,2-dimethylaziridine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.516; FYEGWALDOWGEQR; [M+H]+; 5,5-dimethyl-4H-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.489; GOHZKUSWWGUUNR; [M+H]+; Cocoyl imidazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.951; YJBPEAHLEMYMEC; [M+H]+; Methylcyclopropanecarbonylhydrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -261.175; DEAGOJXAHZYVRR; [M+H]+; N-Hydroxy-cyclobutanecarboxamidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -268.221; OHCXSLPXSUWTKQ; [M+H]+; Xinomilina
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.645; ZMXDDKWLCZADIW; [M+C2H3N+H]+; bmse000709
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.425; DRRVROVYLJHJIV; [M+H]+; zlchem 612
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -45.618; PCXDJQZLDDHMGX; [M+C2H3N+H]+; 3-Aminopropanal
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -57.716; BCDGQXUMWHRQCB; [M+C2H3N+H]+; Aminoacetone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -70.579; OHLUUHNLEMFGTQ; [M+C2H3N+H]+; N-Methylacetamide-N-D1
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -71.767; KPTCZURLWZSRKB; [M+C2H3N+H]+; o-Allylhydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -76.700; QPMCUNAXNMSGTK; [M+C2H3N+H]+; (2R)-2-amino(120C)propanal
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -78.515; KZMQZFPRPILIHO; [M+C2H3N+H]+; Methyl(2-oxoethyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.850; QLNJFJADRCOGBJ; [M+C2H3N+H]+; (213C)propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -90.256; CIISBYKBBMFLEZ; [M+C2H3N+H]+; 1,2-Oxazolidin-2-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -90.620; KJCIMSSFGUGTGA; [M+H]+; 1-Methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -93.028; KERBAAIBDHEFDD; [M+C2H3N+H]+; N-Ethylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -96.054; MSSDTZLYNMFTKN; [M+H]+; 1-Formylpiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -100.933; ZMXDDKWLCZADIW; [M+C2H3N+H]+; N,N-di((114C)methyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -101.122; KVIZTDNKHOCNAM; [M+H]+; 4-Methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -114.433; CYSGHNMQYZDMIA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.998; ZCOGQSHZVSZAHH; [M+H]+; 1-Aziridinecarboxamide, N,N-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -131.482; SODLPCCEKPQWAY; [M+H]+; (5R)-5-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -133.646; VPZBJFGUILDYED; [M+H]+; 1-Deuterio-3,5-dimethylimidazolidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -134.857; ASFOHWKEKBODLZ; [M+H]+; (R)-6-Methyl-piperazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -136.768; YUJHTWYBKVAQEN; [M+H]+; 1-(3-Aminoazetidin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -144.388; UIYPGDYKWVLEDA; [M+H]+; 1,5-Dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.812; PCXDJQZLDDHMGX; [M+C2H3N+H]+; 3-Aminopropanal
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.325; KJCIMSSFGUGTGA; [M+H]+; 1-Methylpiperazin-2-one
COMMENT: CONFIDENCE Level 3: Tentative candidate, N,N-Dimethylformamide, ZMXDDKWLCZADIW-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MS-FINDER:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0001888;
CH$NAME: N,N-Dimethylformamide
CH$NAME: N,N-dimethylformamide
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C3H7NO
CH$EXACT_MASS: 73.052764
CH$SMILES: CN(C)C=O
CH$IUPAC: InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3
CH$LINK: CHEBI CHEBI:17741
CH$LINK: HMDB HMDB0001888
CH$LINK: INCHIKEY ZMXDDKWLCZADIW-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:6228
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 3.162
MS$FOCUSED_ION: ION_TYPE [M+ACN+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 115.086565
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-01b9-9600000000-bc27b0064522f27f8a21
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0651489 22.8522 58.065785 1.7566 6.21 -0.0619 46 f{C3H8N1}/0.40ppm,p-C1N1O1
  69.0446694 37.6601 69.045295 1.3035 9.40 0.1748 58 f{C3H5N2}/-0.80ppm,p-C1H3O1
  70.0287403 92.4979 70.029360 1.0424 14.34 0.1987 59 f{C3H4N1O1}/0.00ppm,p-C1H4N1
  70.0651505 774.2289 70.065770 0.3140 159.40 0.9354 59 f{C4H8N1}/0.35ppm,p-N1O1
  71.0603868 214.4545 71.061000 0.5488 37.19 0.2123 59 f{C3H7N2}/0.17ppm,p-C1H1O1
  72.0444035 434.8743 72.045010 0.3470 35.79 0.4867 59 f{C3H6N1O1}/0.18ppm,p-C1H2N1
  72.0573235 55.5330 72.057930 1.2351 12.06 -0.0192 59 f{C4H8O1}/4.96ppm,p-N2
  72.0637036 254.7134 72.064310 0.4579 43.40 0.0971 59 ?
  72.0807137 39.8348 72.081320 1.3180 10.76 -0.2463 56 ?
  73.0759209 30.8359 73.076520 1.5874 10.12 0.1748 45 ?
  74.0599684 62.2085 74.060560 1.0802 12.02 0.3373 59 f{C3H8N1O1}/-0.97ppm,p-C1N1
  86.0600533 233.1895 86.060520 0.5926 24.05 0.4001 59 f{C4H8N1O1}/0.15ppm,p-N1
  87.0552964 46.9104 87.055750 1.1602 11.31 0.1486 59 f{C3H7N2O1}/0.08ppm,p-C1H1
  87.0916969 594.0873 87.092150 0.2985 61.74 0.1647 59 ?
  97.0396447 61.6135 97.039990 1.1851 12.94 0.2369 59 f{C4H5N2O1}/0.06ppm,p-H3
  97.0760750 94.3815 97.076420 1.2464 18.27 0.6583 59 ?
  98.0600826 30.4411 98.060420 1.8254 7.98 0.2999 52 ?
  115.0502492 999.0000 115.050420 0.2781 46.04 0.4400 59 ?
  115.0693744 42.1759 115.069545 2.3812 7.51 0.3131 58 ?
  115.0868496 548.4060 115.087020 0.5995 68.74 1.0000 59 ?
  115.0944197 71.4862 115.094590 2.6239 17.53 0.0817 57 ?
  115.0999298 35.1927 115.100100 2.0156 9.68 0.2529 46 ?
  115.1060399 388.1786 115.106210 0.4952 63.00 0.2885 59 ?
PK$NUM_PEAK: 23
PK$PEAK: m/z int. rel.int.
  58.065149 22.85 22
  69.044669 37.66 37
  70.028740 92.50 92
  70.065150 774.23 774
  71.060387 214.45 214
  72.044403 434.87 434
  72.057324 55.53 55
  72.063704 254.71 254
  72.080714 39.83 39
  73.075921 30.84 30
  74.059968 62.21 62
  86.060053 233.19 233
  87.055296 46.91 46
  87.091697 594.09 594
  97.039645 61.61 61
  97.076075 94.38 94
  98.060083 30.44 30
  115.050249 999.00 999
  115.069374 42.18 42
  115.086850 548.41 548
  115.094420 71.49 71
  115.099930 35.19 35
  115.106040 388.18 388
//
